特发性全面性癫痫中烟碱受体异常的影像生物标志物
本研究纳入34名男性(12例特发性全面性癫痫、10例非病灶性日间局灶性癫痫、12名年龄匹配健康对照),采用F-A-85380与FDG PET/CT、3D T1 MRI及DTI比较烟碱受体可用性。结果显示IGE患者前扣带回皮层F-A-85380结合潜力比值指数(BPRI)显著升高,且MRI未见结构改变;个体水平上ACC的BPRI升高可较好区分IGE与对照及局灶性癫痫患者。
要点
- IGE患者前扣带回皮层F-A-85380 BPRI较对照显著升高,MRI无结构改变。
- 个体水平ACC的BPRI升高可较好区分IGE与健康对照及局灶性癫痫患者。
- 数据提示α4β2烟碱受体调节可能参与IGE等遗传背景癫痫综合征。
核心结论
- IGE患者存在前扣带回皮层烟碱受体密度/可用性的局灶性改变,即BPRI升高。
- 上述改变提示α4β2烟碱受体调节不仅参与ADNFLE,也可能参与IGE等遗传性癫痫综合征,并可能作为遗传背景癫痫综合征的生物标志物。
研究设计与样本
- 纳入34名男性参与者:12例特发性全面性癫痫(IGE)、10例非病灶性日间局灶性癫痫、12名年龄匹配健康对照。
- 所有患者接受F-A-85380与FDG PET/CT、3D T1 MRI及扩散张量成像(DTI)检查。
- F-A-85380与FDG图像采用体素水平(SPM12)和感兴趣体积(VOI)分析与对照组比较。
主要发现
- IGE组体素水平与VOI分析均显示前扣带回皮层(ACC)F-A-85380结合潜力比值指数(BPRI,对应受体可用性)显著升高,MRI未见结构改变。
- 个体水平上,ACC的F-A-85380 BPRI升高可较好区分IGE患者与对照及局灶性癫痫患者。
关键数值与推荐
- 原文未报告具体BPRI数值、阈值、P值或诊断准确率等定量指标。
临床怎么用
- 原文未报告临床实践推荐。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Mutations of cholinergic neuronal nicotinic receptors have been identified in the autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE), associated with changes on PET images using [18F]-F-85380-A (F-A-85380), an α4β2 nicotinic receptor ligand. The aim of the present study was to evaluate potential changes in nicotinic receptor availability in other types of epilepsy. METHODS: We included 34 male participants, 12 patients with idiopathic generalized epilepsy (IGE), 10 with non-lesional diurnal focal epilepsy, and 12 age-matched healthy controls. All patients underwent PET/CT using F-A-85380 and [18F]-fluorodeoxyglucose (FDG), 3D T1 MRI and diffusion tensor imaging (DTI). F-A-85380 and FDG images were compared with the control group using a voxel-wise (SPM12) and a volumes of interest (VOI) analysis. RESULTS: In the group of patients with IGE, the voxel-wise and VOI analyses showed a significant increase of F-A-85380 ratio index of binding potential (BPRI, corresponding to the receptor availability) in the anterior cingulate cortex (ACC), without structural changes on MRI. At an individual level, F-A-85380 BPRI increase in the ACC could distinguish IGE patients from controls and from patients with focal epilepsy with good accuracy. CONCLUSIONS: We observed focal changes of density/availability of nicotinic receptors in IGE, namely an increase in the ACC. These data suggest that the modulation of α4β2 nicotinic receptors plays a role not only in ADNFLE, but also in other genetic epileptic syndromes such as IGE and could serve as a biomarker of epilepsy syndromes with a genetic background.
引用
- Garibotto V, Wissmeyer M, Giavri Z, et al. Nicotinic receptor abnormalities as a biomarker in idiopathic generalized epilepsy. Eur J Nucl Med Mol Imaging. 2018. PMID: 30269157. doi:10.1007/s00259-018-4175-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。